Minnesota Enacts Landmark Ban on Prediction Markets Making Operation a Felony US 10Year Bond Yield Emerges as Key Driver of Global Financial Markets US April Payrolls Surge Past Forecasts Yet Underlying Weaknesses Emerge Diodes Inc CEO Gary Yu Sells 399810 in Stock Insider Transaction Highlights Russias State Duma Passes Law Allowing Central Bank to Operate AntiDrone Systems New York Fed Study Reveals Disproportionate Impact of Rising Gas Prices on LowerIncome Households Tidewater Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines ECVT Q1 2026 Earnings Earnings Surge Past Estimates with 975 Surprise NYAX Q1 2026 Earnings EPS Falls Short of Estimates Despite Strong Stock Reaction GRAL Q1 2026 Earnings EPS Beat Driven by Cost Control Amidst Uncertain Revenue Trajectory Avnet AVT Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Enova International ENVA Q1 2026 Earnings EPS Beats Estimates by 335 Stock Rises FB Bancorp Inc FBLA Holds Steady at 1402 as Key Levels Define the Trading Range Digital Asset Acquisition Corp Warrant DAAQW Surges Over 8 Testing Key Resistance Levels Praxis Precision Medicines PRAX Edges Lower Following Recent Rally Key Support Tested WiMi Hologram Cloud WIMI Surges 636 as Bulls Test Key Resistance Near 181 Broadstone Net Lease BNL Slips Slightly as Resistance Holds Firm DeepSeek AI Model Triggers SafeHaven Flows Yen and Swiss Franc Strengthen Against Dollar ZWS Q1 2026 Earnings EPS Surges Past Estimates with 116 Beat PFH Prudential Financial Junior Subordinated Notes Holds Steady Near 1623 Amid Narrow Trading Range XPON Q2 2025 Earnings EPS Beats Estimates by 307 Despite Absent Revenue Data VUZI Q1 2026 Earnings NarrowerThanExpected Loss Fails to Reverse Stock Decline Viant Technology Inc DSP Q1 2026 Earnings EPS Misses Estimates Despite 173 Stock Gain ATHM Q4 2025 Earnings Narrow EPS Miss Sends Stock Slightly Lower SYNA Q1 2026 Earnings EPS Surges Past Expectations Lifting Shares 6 RNST Q1 2026 Earnings EPS Surpasses Expectations Amid Challenging Banking Environment ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline